LAVA Therapeutics N.V. (LVTX) Tops Q3 EPS by 15c

LAVA Therapeutics N.V. (NASDAQ: LVTX) reported Q3 EPS of ($0.34), $0.15 better than the analyst estimate of ($0.49).

For earnings history and earnings-related data on LAVA Therapeutics N.V. (LVTX) click here.

You May Also Be Interested In

• AI trade In focus, Iran sanctions loom - What’s moving markets
• UBS Starts Jersey Mike's Subs (JMKE) at Buy
• Kura Oncology (KURA) Reiterated at Market Outperform by Citizens Post Q2 Results